Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With Compensated Cirrhosis and With or Without Human Immunodeficiency Virus Co-Infection
Clinical trial NCT03235349 · COMPLETED
Trial details
- NCT number
- NCT03235349
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-29
- Primary completion
- 2018-11-15
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.